Innovent Biologics, Inc. (IVBXF)
OTCMKTS
· Delayed Price · Currency is USD
10.50
+0.26 (2.54%)
Jul 3, 2025, 9:30 AM EDT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $18.77 billion as of July 3, 2025. Its market cap has increased by 158.44% in one year.
Market Cap
18.77B
Enterprise Value
18.09B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.50
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 18.77B, an increase of 694.05%. That is a compound annual growth rate of 36.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.60B |
Veradigm | 823.67M |
Nika Pharmaceuticals | 708.22M |
Elite Pharmaceuticals | 639.84M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 557.29M |
American Oncology Network | 418.01M |
Northwest Biotherapeutics | 366.72M |